Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

Written Testimony of David A. Prentice, Ph.D., in Support of Ethical Alternatives to Aborted Fetal Tissue Research

On Thursday, December 13, 2018, the U.S. House of Representatives subcommittee on Healthcare, Benefits, and Administrative Rules and Government Operations for the Committee on Oversight and Government Reform held a hearing on “Exploring Alternatives to Fetal Tissue Research.” The hearing was called as the U.S. Department of Health and Human Services re-evaluates funding for research using tissue from aborted babies. Charlotte Lozier Institute’s Vice President and Research Director David A. Prentice, Ph.D., submitted the following written testimony in support of using ethical alternatives to aborted fetal tissue research.

 

To view Prentice’s testimony in PDF format, please see, “Written Testimony of David A. Prentice, Ph.D., In Support of Ethical Alternatives to Aborted Fetal Tissue Research.

 

 

 

Latest Posts

August 7, 2026 A hand in a blue glove holds a box labeled Mifepristone Tablets with a barcode and description stating its use for pregnancy termination and medical abortion, while recent controversies have brought increased attention to both Mifepristone and its uses beyond abortion. Uses for Mifepristone Beyond Abortion: Addressing Recent Controversies July 20, 2026 A woman in a hospital gown is in labor, holding someone's hand for support while medical staff assist during childbirth, closely monitoring for any medical indications that might require separating mother and unborn child. Fact Sheet: Medical Indications for Separating a Mother and Her Unborn Child July 20, 2026 Abortion Reporting: Wyoming (2025)

You Might Also Be Interested In

A digital illustration of multiple blue cells with prominent nuclei floating in a blue background, representing a microscopic view of biological cells derived from human embryonic stem cells.

Public Comment: Lozier Institute on NIH’s Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research

charlotte-lozier-institute Charlotte Lozier Institute
April 29, 2026
Please login to bookmark Close

Alternatives to In Vitro Fertilization (IVF) for Overcoming Infertility and Delivering a Healthy Baby

June 10, 2025
Please login to bookmark Close

In Vitro Fertilization (IVF): A Comprehensive Primer

December 17, 2024
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image